Latest filing published 29 Jul 2026 for Dyne Therapeutics, Inc., €5.7M. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
All filings by Dirk Kersten on record concern Dyne Therapeutics, Inc., in the capacity of senior executive. The record holds 39 filings, for trades running from 9 January 2024 to 27 July 2026.
Market trades split into 1 purchase (€4.6M) and 38 sales (€49.2M). The totals do not cover 5 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings no purchases and 14 sales.
The record was last updated on 29 July 2026 with an open-market sale (€5.7M) in Dyne Therapeutics, Inc. The latest purchase dates back some time: it was published 1,011 days ago, on 11 January 2024. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 39 declarations